In particular, compounds that specifically interfere with the interaction of endothelinpeptides with the ET.sub.A, ET.sub.B or other receptors should may aid in the design of therapeutic agents, and may be useful as disease specific therapeutic agents.Therefore, it is an object herein to provide compounds that have the ability to modulate the biological activity of one or more of the endothelin is